A two-component blend of BPC-157 and TB-500 in a single sealed vial. Combined total 10MG (5mg + 5mg) or 20MG (10mg + 10mg). BPC-157 is a synthetic pentadecapeptide; TB-500 is the actin-binding fragment of thymosin beta-4.
Independently assayed by Janoshik Analytical, task #213495: the 10MG (5+5) batch recorded 11.63mg of measured content against a 10mg label claim. The result applies only to the batch identified on that certificate.
Supplied as a lyophilised powder. Store the sealed vial cold and out of direct light. Reconstitute with bacteriostatic water; hold at 2-8°C, protect from light and freezing, do not refreeze. Supplied for laboratory research use only. Not for human or veterinary consumption.
SECTION 03 · INDEPENDENT ANALYSIS
The analysis.
Third-party tested. Publicly verifiable.
JANOSHIK ANALYTICAL
INDEPENDENT TESTING LABORATORY
Tested: BPC-157/TB-500 10mg
TASK NUMBER
#213495
SAMPLE RECEIVED
03 AUG 2026
ANALYSIS CONDUCTED
05 AUG 2026
CONTENT MEASURED
11.63MG
LABEL CLAIM · 10 MG
VERIFICATION KEY
EA2U5VMESFKR
Enter this key at janoshik.com/verify to confirm this report independently.
We do not host it.